Organization and architecture of a Center for cellular resolution analysis of Alzheimer's disease

阿尔茨海默病细胞分辨率分析中心的组织和架构

基本信息

  • 批准号:
    10112798
  • 负责人:
  • 金额:
    $ 41.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT (ADMIN CORE) The Center proposal “A platform for cell type-level transcriptomic, epigenomic and spatial interrogation of Alzheimer’s disease” proposal aims to combine expertise in AD pathology with expertise in new single cell molecular technologies to generate a new high resolution cellular and molecular understanding of the early pathogenesis of AD. The Center consists of three Research Projects, focusing on neuropathology, transcriptomics and epigenomics, and spatial transcriptomics; a Data Core, and an Administrative Core with seven PIs and three collaborative sites. Realizing the potential of this Center requires strong administrative leadership to integrate and synergize efforts across the collaborating researchers at the University of Washington, Kaiser/Group Health and the Allen Institute for Brain Science. The Administrative Core will provide the structure, leadership and operational management of the Center towards achievement of the overall Center goals to understand the cellular and molecular basis of the early pathogenesis of AD. This will include project management, strategic planning, progress reporting, fiscal management, and support for collaboration and communication. The Administrative Core will create an infrastructure that fosters communication and collaboration among the Center members, as well as garnering input from the external AD research community through the formation of an External Scientific Advisory committee. The Center will form a Steering Committee and Project Teams to oversee the collaborative, standardized, and on-time data generation, data analysis, and public data sharing process. Project management best practices, such as milestones, progress reporting and tracking, collaborative software programs, and a responsibility matrix will be applied to the Center to ensure achievement of performance objectives and milestones, optimized communication, and resource utilization and prioritization. In addition, the Core will foster joint data analysis efforts across projects and Institutions, including joint Analysis Working Groups and hackathons. Further, the Administrative Core will support the implementation of standard operating procedures and quality control standards for data generation, data processing, and analysis. To produce a high-quality data resource for high resolution neuropathological and omics analysis of Alzheimer’s disease, rigorous standardization and quality control practices will be adopted by all members. Finally, the Administrative Core will implement and maintain fiscal and subcontractor management processes for all members, manage publication and authorship decisions and conflict resolution. With the implementation of this entire infrastructure, we anticipate that this project and the resources it produces will have a broad and meaningful impact on gaining a deep molecular and cellular understanding of Alzheimer’s disease pathology and progression.
摘要(管理核心) 该中心的建议是“一个细胞类型水平转录、表观基因组和空间查询的平台”。 阿尔茨海默病“提案旨在将AD病理方面的专业知识与新的单细胞专业知识相结合 分子技术产生新的高分辨率细胞和分子的早期理解 阿尔茨海默病发病机制。该中心由三个研究项目组成,重点是神经病理学, 转录学和表观基因组学,以及空间转录学;数据核心和管理核心 七个PI和三个协作站点。实现该中心的潜力需要强有力的行政管理 领导力,以整合和协同合作的研究人员在大学的努力 华盛顿,凯撒/集团健康和艾伦脑科学研究所。 行政核心将提供中心的结构、领导和业务管理 为实现全面的中心目标,以了解早期的细胞和分子基础 阿尔茨海默病发病机制。这将包括项目管理、战略规划、进度报告、财务 管理以及对协作和通信的支持。管理核心将创建一个 基础设施,促进中心成员之间的沟通和合作,并获得 通过形成外部科学咨询,来自外部AD研究界的投入 委员会审议阶段。该中心将成立一个指导委员会和项目团队,以监督协作、 标准化、及时的数据生成、数据分析和公共数据共享流程。项目管理 最佳实践,如里程碑、进度报告和跟踪、协作软件程序以及 将对中心应用责任矩阵,以确保实现业绩目标和 里程碑、优化的通信以及资源利用和优先顺序。此外,核心将促进 跨项目和机构的联合数据分析工作,包括联合分析工作组和 黑客松。此外,行政核心将支持执行标准作业程序 以及数据生成、数据处理和分析的质量控制标准。要产生高质量的数据 阿尔茨海默病的高分辨率神经病理学和组学分析资源,严谨 标准化和质量控制做法将为所有成员所采用。最后,行政核心意志 执行和维护所有成员的财务和分包商管理流程,管理出版物 以及作者身份决定和冲突解决。随着整个基础设施的实施,我们 预计该项目及其产生的资源将对获得 对阿尔茨海默病的病理和进展有深入的分子和细胞理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ed Lein其他文献

Ed Lein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ed Lein', 18)}}的其他基金

Functionally guided adult whole brain cell atlas in human and NHP
人类和 NHP 的功能引导成人全脑细胞图谱
  • 批准号:
    10687245
  • 财政年份:
    2022
  • 资助金额:
    $ 41.74万
  • 项目类别:
Functionally guided adult whole brain cell atlas in human and NHP
人类和 NHP 的功能引导成人全脑细胞图谱
  • 批准号:
    10523848
  • 财政年份:
    2022
  • 资助金额:
    $ 41.74万
  • 项目类别:
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
阿尔茨海默病的区域、细胞类型和分子标志的空间分析
  • 批准号:
    10612895
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
阿尔茨海默病的区域、细胞类型和分子标志的空间分析
  • 批准号:
    10375363
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
使用单细胞转录组学和表观基因组学对阿尔茨海默病进行地形、细胞类型和分子途径表征
  • 批准号:
    10612891
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease
阿尔茨海默病的区域、细胞类型和分子标志的空间分析
  • 批准号:
    10112806
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
使用单细胞转录组学和表观基因组学对阿尔茨海默病进行地形、细胞类型和分子途径表征
  • 批准号:
    10112803
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Organization and architecture of a Center for cellular resolution analysis of Alzheimer's disease
阿尔茨海默病细胞分辨率分析中心的组织和架构
  • 批准号:
    10375358
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Topographic, cell type and molecular pathway characterization ofAlzheimer's disease using single cell transcriptomics and epigenomics
使用单细胞转录组学和表观基因组学对阿尔茨海默病进行地形、细胞类型和分子途径表征
  • 批准号:
    10375362
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:
Organization and architecture of a Center for cellular resolution analysis of Alzheimer's disease
阿尔茨海默病细胞分辨率分析中心的组织和架构
  • 批准号:
    10612880
  • 财政年份:
    2020
  • 资助金额:
    $ 41.74万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 41.74万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了